2017-03-20,Novocure Receives MHLW Approval For Second Generation Optune® In Japan
2017-03-01,Novocure Announces Data Presentations At The American Association For Cancer Research Annual Meeting 2017
2017-02-23,Biotech Movers: Shire Rises on Encouraging Angioedema Results
2017-02-23,Novocure Announces Departure Of Chief Commercial Officer
2017-02-23,Novocure Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Company Update
2017-02-15,First Patient Enrolled In Novocure's Phase 3 Pivotal LUNAR Trial Testing Tumor Treating Fields For The Treatment Of Advanced Non-Small Cell Lung Cancer After Failing Platinum-Based Therapy
2017-02-07,Novocure To Participate In The BIO 2017 CEO & Investor Conference
2017-01-24,Novocure To Participate In Noble Capital Markets' 13th Annual Investor Conference
2017-01-20,Johnson & Weaver, LLP Initiates Investigations Of Rent-A-Center, Inc., KalVista Pharmaceuticals, Inc., NovoCure Limited And Inotek Pharmaceuticals Corp.
2017-01-19,GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open
2017-01-19,Novocure's Optune® Now Available At 500 Cancer Treatment Centers In The U.S.
2017-01-18,RSI Alert: NovoCure (NVCR) Now Oversold
2017-01-12,First Week of February 17th Options Trading For NovoCure (NVCR)
2017-01-10,Novocure Announces Preliminary Fourth Quarter And Full Year 2016 Operating Statistics
2017-01-10,Novocure To Report Fourth Quarter And Full Year 2016 Financial Results
2016-12-22,INVESTOR ALERT: Law Offices Of Howard G. Smith Commences Investigation On Behalf Of NovoCure Limited Investors
2016-12-21,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of NovoCure Limited (NVCR)
2016-12-19,Novocure's Optune® (NovoTTF-100A) Approved In Japan For The Treatment Of Newly Diagnosed Glioblastoma
2016-12-15,Novocure To Participate In 35th Annual J.P. Morgan Healthcare Conference
2016-12-12,Novocure Presents Second Cohort Of Phase 2 Pilot PANOVA Trial Results Suggesting Tumor Treating Fields Plus Nab-Paclitaxel And Gemcitabine May Be Safe As First-Line Treatment And May Improve One-Year Survival Rate Of Patients With Advanced Pancreatic Cancer
2016-12-12,Novocure Presents Phase 2 Pilot INNOVATE Trial Results Suggesting Tumor Treating Fields Plus Paclitaxel May Be Safe As First-Line Treatment And May Improve Survival Of Patients With Recurrent Ovarian Cancer
2016-12-08,Novocure Announces Agenda For Research And Development Day On Dec. 12, 2016
2016-11-22,First Week of January 2017 Options Trading For NovoCure (NVCR)
2016-11-18,Noteworthy Friday Option Activity: NVCR, VHC, TERP
2016-11-18,Long-Term Analysis Of All 695 Patients Enrolled In Novocure's Phase 3 Pivotal Trial In Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results And Demonstrates Superior Two- And Four-Year Survival Rates
2016-11-17,Novocure Presents Interim STELLAR Results At IASLC Suggesting Treatment With Tumor Treating Fields Plus Chemotherapy May Extend Survival Of Patients With Mesothelioma
2016-11-14,Novocure Has Sponsored Pulitzer Prize-winning Author Dr. Siddhartha Mukherjee As The Keynote Speaker Of 21st Annual Scientific Meeting Of The Society For Neuro-Oncology On Nov. 19, 2016, In Scottsdale, Arizona. (Photo: Business Wire)
2016-11-11,Ratings Changes Today
2016-11-07,Novocure Announces 38 Presentations On Tumor Treating Fields At 21st Annual Scientific Meeting Of The Society Of Neuro-Oncology
2016-11-03,Noteworthy Thursday Option Activity: NVCR, TWLO, DHT
2016-11-03,United Healthcare Issues Positive Coverage Decision For Optune
2016-11-02,Novocure Reports Third Quarter 2016 Financial Results And Provides Company Update
2016-11-01,Novocure Recognizes National Family Caregivers Month By Supporting GBM Heroes Event
2016-10-12,Novocure Enrolls First Patient In Phase 3 Pivotal Brain Metastases Trial
2016-09-30,CORRECTING And REPLACING - Novocure To Report Third Quarter 2016 Financial Results
2016-09-30,Novocure To Report Third Quarter 2016 Financial Results
2016-09-19,CNS Oncology Publishes Tumor Treating Fields Treatment Planning And Patient Follow-up Guidelines In Glioblastoma
2016-09-15,Commit To Buy NovoCure At $7.50, Earn 31.9% Annualized Using Options
2016-09-15,Novocure's Executive Chairman William Doyle To Present On Tumor Treating Fields At New York Academy Of Sciences' Symposium On Bioelectronic Medicine
2016-09-14,Two Institutions Publish Independent Data On Novocure's Tumor Treating Fields
2016-09-12,Martin Romero Sanchez Of Houston, Texas, Is An Optune Patient.
2016-09-01,International Journal Of Cancer Publishes Data Showing Tumor Treating Fields In Combination With Paclitaxel Is Therapeutically Effective Against Ovarian Cancer Cells In Vitro And In Vivo
2016-09-01,'Mad Money' Lightning Round: I'm Staying With Potash
2016-08-31,Jim Cramer's 'Mad Money' Recap: Oil Regains Control of the Stock Market
2016-08-29,NovoCure is Now Oversold (NVCR)
2016-08-16,(Photo: Business Wire)
2016-08-10,Short Interest In NovoCure Moves 11.5% Lower
2016-08-08,Novocure To Present At Upcoming Investor Conferences
2016-07-28,NovoCure Enters Oversold Territory (NVCR)
2016-07-28,Novocure Reports Second Quarter 2016 Financial Results And Provides Company Update
2016-07-28,Novocure To Host Research And Development Day On Dec. 12, 2016
2016-07-26,NCCN Guidelines Recommend Optune As A Standard Treatment Option For Newly Diagnosed Glioblastoma
2016-07-13,Novocure's New System Aims To Make Optune Therapy Even Easier For Glioblastoma Patients. Actor Portrayal. (Photo: Business Wire)
2016-06-30,Novocure Announces $75 Million Drawdown Under Its Term Loan Agreement Through Pharmakon Advisors
2016-06-30,Novocure To Report Second Quarter 2016 Financial Results
2016-06-20,Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan
2016-06-18,'Mad Money' Lightning Round: Buy, Buy, Buy Edward Lifesciences
2016-06-08,Novocure To Present At JMP Securities 2016 Life Sciences Conference
2016-05-31,Novocure Receives IDE Approval To Initiate METIS Trial
2016-05-23,Novocure Enrolls Last Patient In PANOVA Trial Of Tumor Treating Fields Plus Chemotherapy In Advanced Pancreatic Cancer
2016-05-19,Novocure Enrolls Last Patient In INNOVATE Trial Testing Tumor Treating Fields Plus Paclitaxel In Recurrent Ovarian Cancer
2016-05-18,Novocure Announces Presentation Of Subgroup Analysis Of PANOVA Data Showing Overall Survival Benefit Of Tumor Treating Fields Plus Gemcitabine In Advanced Pancreatic Cancer Patients
2016-05-13,Novocure To Present New Preclinical Data Showing Additive Efficacy Of Tumor Treating Fields And PD-1 Inhibitors At The American Association Of Immunologists' Annual Meeting 2016
2016-05-12,Bill Doyle's Pershing Exit Adds to Disastrous Quarter for Bill Ackman
2016-05-11,Novocure Enters Into Employment Agreement With William Doyle
2016-05-09,Novocure Reports First Quarter 2016 Financial Results And Provides Company Update
2016-05-06,Novocure Kicks Off Brain Tumor Awareness Month With New Activities To Support And Inspire Those Affected By Glioblastoma
2016-05-05,Novocure Delivers New Informational Resource For Glioblastoma Brain Cancer
2016-05-04,Blue Cross Blue Shield Of Michigan Issues Positive Coverage Decision For Optune
2016-04-26,Novocure's Optune Now Available At More Than 360 Cancer Treatment Centers In The U.S.
2016-04-25,FDA Approves Investigational Device Exemption For RTOG Trial Of Novocure's Optune Together With Bevacizumab For Patients With Bevacizumab-Refractory Recurrent Glioblastoma
2016-04-07,Jim Cramer's 'Mad Money' Recap: Uncle Sam, Back Off Business!
2016-04-07,Novocure To Present New Preclinical Data On Tumor Treating Fields At American Association For Cancer Research Annual Meeting 2016
2016-04-05,Novocure To Report First Quarter 2016 Financial Results
2016-03-09,Red Journal Publishes Data Supporting Personalized Treatment Planning To Increase TTFields Efficacy For Patients With Glioblastoma
2016-03-03,Humana Issues Positive Coverage Decision For Optune
2016-02-29,Novocure Reports 2015 Operating Statistics And Financial Results
2016-02-23,Novocure To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-22,Jim Cramer's 'Mad Money' Recap: This Week's Game Plan
2016-02-12,Anthem Inc. Issues Positive Coverage Decision For Optune In Newly Diagnosed Glioblastoma
2016-02-08,Novocure's Phase 3 Pivotal Trial Results In Newly Diagnosed Glioblastoma Selected For ASCO's Clinical Cancer Advances 2016 Report
2016-02-01,Novocure To Report Fourth Quarter, Year-End Financial Results
2016-01-19,Novocure Presents Phase 2 PANOVA Results At ASCO GI Suggesting Tumor Treating Fields Therapy Plus Chemotherapy May Be Safe As First-Line Treatment And Improve Survival Of Patients With Advanced Pancreatic Cancer
2016-01-11,Novocure Announces Preliminary 2015 Operating Statistics
2016-01-07,Novocure Submits PMA Partial Amendment Application To Japanese Pharmaceuticals And Medical Devices Agency For Treatment Of Newly Diagnosed Glioblastoma Patients
2016-01-07,Oversold Conditions For NovoCure (NVCR)
2016-01-06,Novocure Files Premarket Approval Supplement Application With FDA For Second Generation Optune System
2016-01-04,Novocure To Participate In 34th Annual J.P. Morgan Healthcare Conference
2015-12-18,5 Stocks Ready for Breakouts
2015-12-15,Novocure To Hold Webcast To Discuss JAMA Publication Of EF-14 Phase 3 Clinical Trial Data
2015-12-15,Journal Of The American Medical Association (JAMA) Publishes Pivotal Phase 3 Data For Optune Plus Temozolomide To Treat Newly Diagnosed Glioblastoma
2015-12-14,New Data On Tumor Treating Fields' Anti-Mitotic Mechanism Of Action Published In Scientific Reports
2015-12-08,5 Outperforming Stocks to Watch
2015-12-07,Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan
2015-12-05,Jim Cramer's Top Takeaways: Zoe's, Novocure, Ulta Salon, PVH
2015-12-03,Retrospective Analysis Shows Optune Safe In Glioblastoma Patients With Implanted Non-Programmable Shunts
2015-12-02,Preliminary Phase 2 Data Demonstrate Tumor Treating Fields Is Safe In Patients With Brain Metastases Originating From Non-Small Cell Lung Cancer
2015-11-20,New Phase 3 Data Show Optune In Combination With Second Line Chemotherapy Is Superior To Second Line Chemotherapy Alone In Glioblastoma Patients At First Recurrence
2015-11-17,Novocure Announces Webcast To Discuss New EF-14 Clinical Trial Analyses And Tumor Treating Fields Presentations From SNO 2015
2015-11-17,Novocure Announces 18 Presentations On Tumor Treating Fields At SNO 2015 Including New Analyses Of The EF-14 Newly Diagnosed Glioblastoma Clinical Trial Data
2015-10-26,Novocure Reports Third Quarter 2015 Operating And Financial Results
2015-10-23,'Mad Money' Lightning Round: I See Waste Management Rising to $60
2015-10-22,Jim Cramer's 'Mad Money' Recap: Surprises Turn Market on Its Head
2015-10-19,NovoCure Limited Announces Closing Of Partial Exercise Of IPO Over-Allotment Option
2015-10-16,Novocure To Offer On Demand Optune Certification Training For The Radiation Oncology Community At ASTRO 2015
2015-10-16,Novocure To Report Third Quarter 2015 Financial Results On Monday, October 26
2015-10-08,Jim Cramer's Top Takeaways: Alkermes, Yum! Brands, Novocure
2015-10-07,Jim Cramer's 'Mad Money' Recap: Watching China Warily, Again
2015-10-07,NovoCure Limited Announces Closing Of Initial Public Offering
2015-10-05,Optune Device (Photo: Business Wire)
2015-10-02,NovoCure Debuts on Nasdaq, Despite Weakness in IPO Market
2015-10-02,September Job Growth a Big Disappointment, U.S. Stocks Open Lower
2015-10-01,NovoCure Limited Announces Launch Of Initial Public Offering
,
,
